94-11098. Statement of Organization, Functions, and Delegations of Authority  

  • [Federal Register Volume 59, Number 88 (Monday, May 9, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-11098]
    
    
    [[Page Unknown]]
    
    [Federal Register: May 9, 1994]
    
    
    -----------------------------------------------------------------------
    
    FEDERAL TRADE COMMISSION
    Food and Drug Administration
    [GN# 2240]
    
     
    
    Statement of Organization, Functions, and Delegations of 
    Authority
    
        Part H, Chapter HF (Food and Drug Administration) of the Statement 
    of Organization, Functions, and Delegations of Authority for the 
    Department of Health and Human Services (35 FR 3685, February 25, 1970 
    and 56 FR 29484, June 27, 1991, as amended most recently in pertinent 
    parts at 51 FR 39424, October 28, 1986) is amended to reflect the 
    following reorganization in the Food and Drug Administration (FDA).
        FDA proposes to revise the substructure of the Office of 
    Legislative Affairs within the Office of External Affairs. The purpose 
    of the revisions to the substructure is to organize around program 
    areas rather than the current oversight and legislative functional 
    areas to increase the efficiency of FDA's legislative and oversight 
    support on issues that pertain to specific programs including 
    biologics, drugs, and devices; and provide the appropriate 
    specialization that is required to more effectively perform these 
    functions.
        Under section HF-B, Organization:
        1. Delete subparagraphs (d-1) Oversight and Investigations Staff 
    (HFADA) and (d-2) Legislation and Special Projects Staff (HFADB) in 
    their entirety and insert the new subparagraphs (d-1) Congressional 
    Affairs Staff I (HFADA), (d-2) Congressional Affairs Staff II (HFADC), 
    and (d-3) Special Projects Staff (HFADD) under paragraph Office of 
    Legislative Affairs (HFAD) under Office of External Affairs (HFAQ) 
    reading as follows:
        Congressional Affairs Staff I (HFADA). Serves as the Agency focal 
    point with Congress, the Department, PHS, and other agencies on all 
    congressional and legislative issues and activities as they pertain to 
    the Center for Food Safety and Applied Nutrition, the Center for 
    Veterinary Medicine, the National Center for Toxicological Research, 
    and cross-cutting Agency organizational components and issues.
        Coordinates and prepares Agency responses to congressional and 
    legislative inquiries and other sensitive correspondence on various 
    issues that affect the Agency including proposed legislation, 
    oversight, investigative, and constituent matters.
        Initiates, coordinates, and provides in-depth analyses of Agency 
    legislative needs and proposed and pending legislation by preparing 
    supporting documents, legislative proposals, and position papers for 
    the Commissioner, Deputy Commissioners, other Agency officials, 
    Congress, and OMB.
        Develops and coordinates testimony for the Agency and the 
    Department for presentation to congressional committees; monitors 
    hearings; and edits transcripts of Agency testimony.
        Provides information on the Agency's legislative programs and 
    proposals to consumers and regulated industry.
        In collaboration with other FDA and Department offices, initiates 
    and conducts appraisals of regulatory and scientific policies to 
    resolve problems pertaining to FDA programs and policies under existing 
    statutes.
        Congressional Affairs Staff II (HFADC). Serves as the Agency focal 
    point with Congress, the Department, PHS, and other agencies on all 
    congressional and legislative issues and activities as they pertain to 
    the Center for Biologics Evaluation and Research, the Center for Drug 
    Evaluation and Research, and the Center for Devices and Radiological 
    Health.
        Coordinates and prepares Agency responses to congressional and 
    legislative inquiries and other sensitive correspondence on various 
    issues that affect the Agency including proposed legislation, 
    oversight, investigative, and constituent matters.
        Initiates, coordinates, and provides in-depth analyses of Agency 
    legislative needs and proposed and pending legislation by preparing 
    supporting documents, legislative proposals, and position papers for 
    the Commissioner, Deputy Commissioners, other Agency officials, 
    Congress, and OMB.
        Develops and coordinates testimony for the Agency and the 
    Department for presentation to congressional committees; monitors 
    hearings; and edits transcripts of Agency testimony.
        Provides information on the Agency's legislative programs and 
    proposals to consumers and regulated industry.
        In collaboration with other FDA and Department offices, initiates 
    and conducts appraisals of regulatory and scientific policies to 
    resolve problems pertaining to FDA programs and policies under existing 
    statutes.
        Special Projects Staff (HFADD). Coordinates studies and 
    investigations of Agency components that are conducted by outside 
    organizations including the Office of Technology Assessment (OTA), 
    Congressional Research Service (CRS), and the General Accounting Office 
    (GAO).
        Monitors all GAO/OTA activities regarding FDA.
        Under Section HF-D, Delegation of Authority. Pending further 
    delegations, directives, or orders by the Commissioner of Food and 
    Drugs, all delegations of authority to officers or employees of the 
    Office of Legislative Affairs in effect prior to this date shall 
    continue in effect in them or their successors.
    
        Dated: April 12, 1994.
    David A. Kessler,
    Commissioner of Food and Drugs.
    [FR Doc. 94-11098 Filed 5-6-94; 8:45 am]
    BILLING CODE 4160-01-M
    
    
    

Document Information

Published:
05/09/1994
Department:
Food and Drug Administration
Entry Type:
Uncategorized Document
Document Number:
94-11098
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: May 9, 1994, GN# 2240